Contact
searchSearch
HMP Global

Atrial Fibrillation Topic Center

Featured Article

News
Bleeding Events, Hospitalizations Among Patients with AF
04/23/2018
Blake Charlton, MD a clinical fellow at the University of California, San Francisco School of Medicine, discusses his recent study that examined how NOACs and warfarin impact patients with atrial fibrillation differently.
Blake Charlton, MD a clinical fellow at the University of California, San Francisco School of Medicine, discusses his recent study that examined how NOACs and warfarin impact patients with atrial fibrillation differently.
Blake Charlton, MD a clinical...
04/23/2018
Pharmacy Learning Network
From Pharmacy Learning Network
News
Apixaban Effective in AF Patients Scheduled for Cardioversion
04/16/2018
Researchers recently examined the safety and efficacy of apixaban for anticoagulation in patients with atrial fibrillation scheduled for cardioversion.
Researchers recently examined the safety and efficacy of apixaban for anticoagulation in patients with atrial fibrillation scheduled for cardioversion.
Researchers recently examined...
04/16/2018
Pharmacy Learning Network
From Pharmacy Learning Network
News
Drug Raises Mortality Risk in Patients with AF
03/06/2018
A drug is associated with an increased risk of mortality among patients with atrial fibrillation with and without heart failure, recent research suggests.
A drug is associated with an increased risk of mortality among patients with atrial fibrillation with and without heart failure, recent research suggests.
A drug is associated with an...
03/06/2018
Pharmacy Learning Network
From Pharmacy Learning Network
News
Preventing Sudden Death in AF Patients
05/05/2017
Digoxin serum concentration should be monitored in patients with AF to ensure blood levels stay below what level?
Digoxin serum concentration should be monitored in patients with AF to ensure blood levels stay below what level?
Digoxin serum concentration...
05/05/2017
Pharmacy Learning Network
From Pharmacy Learning Network
News
What’s the Best Treatment for AF Patients With Major Bleeding Event?
03/04/2017
A patient suffers a major bleeding event while on anticoagulation therapy to treat atrial fibrillation. What should you do?
A patient suffers a major bleeding event while on anticoagulation therapy to treat atrial fibrillation. What should you do?
A patient suffers a major...
03/04/2017
Pharmacy Learning Network
From Pharmacy Learning Network
News
Beta-Blockers` Value for Heart Failure with A-Fib Reaffirmed
01/30/2017
Beta-blockers may be an effective treatment for patients with atrial fibrillation and heart failure with a reduced ejection fraction than other therapy types.
Beta-blockers may be an effective treatment for patients with atrial fibrillation and heart failure with a reduced ejection fraction than other therapy types.
Beta-blockers may be...
01/30/2017
Pharmacy Learning Network
From Pharmacy Learning Network
Atrial Fibrillation: Updates and Insights
01/24/2017
A number of new studies have shed light on some important questions related to atrial fibrillation care.
A number of new studies have shed light on some important questions related to atrial fibrillation care.
A number of new studies have...
01/24/2017
Pharmacy Learning Network
From Pharmacy Learning Network
News
Which Anticoagulant Can Reduce Risk of Drug-Drug Interactions?
01/20/2017
Which anticoagulant carries the lowest risk of metabolic drug-drug interactions?
Which anticoagulant carries the lowest risk of metabolic drug-drug interactions?
Which anticoagulant carries the...
01/20/2017
Pharmacy Learning Network
From Pharmacy Learning Network
News
Updated Guidelines for Atrial Fibrillation
01/13/2017
A task force from the ACC provides guidance for the periprocedural management of anticoagulation in individuals with nonvalvular atrial fibrillation.
A task force from the ACC provides guidance for the periprocedural management of anticoagulation in individuals with nonvalvular atrial fibrillation.
A task force from the...
01/13/2017
Pharmacy Learning Network
From Pharmacy Learning Network
News
Anticoagulant Recalled
12/22/2016
Cantrell Drug Company is recalling 1494 syringes of an anticoagulant after they identified sterility problems, according the FDA's latest Drug Enforcement Report.
Cantrell Drug Company is recalling 1494 syringes of an anticoagulant after they identified sterility problems, according the FDA's latest Drug Enforcement Report.
Cantrell Drug Company is...
12/22/2016
Pharmacy Learning Network
From Pharmacy Learning Network
News
When to Reduce Apixaban Dose
12/08/2016
Should the twice-daily dose of the anticoagulant apixaban be reduced from 5 mg to 2.5 mg for an 85-year-old atrial fibrillation patient with renal dysfunction?  
Should the twice-daily dose of the anticoagulant apixaban be reduced from 5 mg to 2.5 mg for an 85-year-old atrial fibrillation patient with renal dysfunction?  
Should the twice-daily dose of...
12/08/2016
Pharmacy Learning Network
From Pharmacy Learning Network

Newsfeed

News
Bleeding Events, Hospitalizations Among Patients with AF
04/23/2018
Blake Charlton, MD a clinical fellow at the University of California, San Francisco School of Medicine, discusses his recent study that examined how NOACs and warfarin impact patients with atrial fibrillation differently.
Blake Charlton, MD a clinical fellow at the University of California, San Francisco School of Medicine, discusses his recent study that examined how NOACs and warfarin impact patients with atrial fibrillation differently.
Blake Charlton, MD a clinical...
04/23/2018
Pharmacy Learning Network
News
Apixaban Effective in AF Patients Scheduled for Cardioversion
04/16/2018
Researchers recently examined the safety and efficacy of apixaban for anticoagulation in patients with atrial fibrillation scheduled for cardioversion.
Researchers recently examined the safety and efficacy of apixaban for anticoagulation in patients with atrial fibrillation scheduled for cardioversion.
Researchers recently examined...
04/16/2018
Pharmacy Learning Network
News
Drug Raises Mortality Risk in Patients with AF
03/06/2018
A drug is associated with an increased risk of mortality among patients with atrial fibrillation with and without heart failure, recent research suggests.
A drug is associated with an increased risk of mortality among patients with atrial fibrillation with and without heart failure, recent research suggests.
A drug is associated with an...
03/06/2018
Pharmacy Learning Network
News
Preventing Sudden Death in AF Patients
05/05/2017
Digoxin serum concentration should be monitored in patients with AF to ensure blood levels stay below what level?
Digoxin serum concentration should be monitored in patients with AF to ensure blood levels stay below what level?
Digoxin serum concentration...
05/05/2017
Pharmacy Learning Network
News
What’s the Best Treatment for AF Patients With Major Bleeding Event?
03/04/2017
A patient suffers a major bleeding event while on anticoagulation therapy to treat atrial fibrillation. What should you do?
A patient suffers a major bleeding event while on anticoagulation therapy to treat atrial fibrillation. What should you do?
A patient suffers a major...
03/04/2017
Pharmacy Learning Network
News
Beta-Blockers` Value for Heart Failure with A-Fib Reaffirmed
01/30/2017
Beta-blockers may be an effective treatment for patients with atrial fibrillation and heart failure with a reduced ejection fraction than other therapy types.
Beta-blockers may be an effective treatment for patients with atrial fibrillation and heart failure with a reduced ejection fraction than other therapy types.
Beta-blockers may be...
01/30/2017
Pharmacy Learning Network
News
Which Anticoagulant Can Reduce Risk of Drug-Drug Interactions?
01/20/2017
Which anticoagulant carries the lowest risk of metabolic drug-drug interactions?
Which anticoagulant carries the lowest risk of metabolic drug-drug interactions?
Which anticoagulant carries the...
01/20/2017
Pharmacy Learning Network
News
Updated Guidelines for Atrial Fibrillation
01/13/2017
A task force from the ACC provides guidance for the periprocedural management of anticoagulation in individuals with nonvalvular atrial fibrillation.
A task force from the ACC provides guidance for the periprocedural management of anticoagulation in individuals with nonvalvular atrial fibrillation.
A task force from the...
01/13/2017
Pharmacy Learning Network
News
Anticoagulant Recalled
12/22/2016
Cantrell Drug Company is recalling 1494 syringes of an anticoagulant after they identified sterility problems, according the FDA's latest Drug Enforcement Report.
Cantrell Drug Company is recalling 1494 syringes of an anticoagulant after they identified sterility problems, according the FDA's latest Drug Enforcement Report.
Cantrell Drug Company is...
12/22/2016
Pharmacy Learning Network
News
When to Reduce Apixaban Dose
12/08/2016
Should the twice-daily dose of the anticoagulant apixaban be reduced from 5 mg to 2.5 mg for an 85-year-old atrial fibrillation patient with renal dysfunction?  
Should the twice-daily dose of the anticoagulant apixaban be reduced from 5 mg to 2.5 mg for an 85-year-old atrial fibrillation patient with renal dysfunction?  
Should the twice-daily dose of...
12/08/2016
Pharmacy Learning Network
News
Increased Scrutiny of Prior Authorization: Are Payers Fully to Blame, and Can AI Improve the Process?
04/05/2024
The increased scrutiny of prior authorization, highlighted by media reports and government actions, prompts debate over payer responsibility while exploring the potential for AI to enhance the process.
The increased scrutiny of prior authorization, highlighted by media reports and government actions, prompts debate over payer responsibility while exploring the potential for AI to enhance the process.
The increased scrutiny of prior...
04/05/2024
First Report Managed Care
News
PhRMA Maps Provide State-by-State Look at 340B Drug Program
04/05/2024
An interactive map made available by the Pharmaceutical Research and Manufacturers of America (PhRMA), a drugmaker advocacy group, shares state-specific data on the 340B Drug Pricing Program. The federal program, initially created over 30...
An interactive map made available by the Pharmaceutical Research and Manufacturers of America (PhRMA), a drugmaker advocacy group, shares state-specific data on the 340B Drug Pricing Program. The federal program, initially created over 30...
An interactive map made...
04/05/2024
First Report Managed Care
News
FTC and HHS Launch Joint Inquiry into Generic Drug Shortages: Seeking Public Input on GPOs and Wholesalers
02/16/2024
In a news release published on February 14, 2024, the US Department of Health and Human Services (HHS) issued a "Request for Information" in collaboration with the Federal Trade Commission (FTC). This request aims to gain insight into how...
In a news release published on February 14, 2024, the US Department of Health and Human Services (HHS) issued a "Request for Information" in collaboration with the Federal Trade Commission (FTC). This request aims to gain insight into how...
In a news release published on...
02/16/2024
First Report Managed Care
News
Medicare Drug Price Negotiations and Anticipated Ripple Effects
02/15/2024
The arrival of the Inflation Reduction Act has ushered in a new era of drug price regulation, giving the Centers for Medicare & Medicaid Services (CMS) the ability to negotiate directly with companies that make some of the costliest drugs...
The arrival of the Inflation Reduction Act has ushered in a new era of drug price regulation, giving the Centers for Medicare & Medicaid Services (CMS) the ability to negotiate directly with companies that make some of the costliest drugs...
The arrival of the Inflation...
02/15/2024
First Report Managed Care
News
Injectable PrEP Overall Acceptable, Preferred for HIV Prevention
07/15/2023
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability,...
07/15/2023
First Report Managed Care
News
First Gene Therapy for Severe Hemophilia A Is Approved
06/29/2023
This approval comes after a safety and effectiveness trial showed that the treatment improved participants’ annualized bleeding rate after 3 years.
This approval comes after a safety and effectiveness trial showed that the treatment improved participants’ annualized bleeding rate after 3 years.
This approval comes after a...
06/29/2023
Population Health
News
Low Rate of Social Determinants of Health Z Codes in Adults With Hypertension
06/26/2023
Researchers examined the presence and use of ICD-10-CM social determinants of health (SDOH)-related Z codes among adults with hypertension and found differences in documentation and medical expenditures.
Researchers examined the presence and use of ICD-10-CM social determinants of health (SDOH)-related Z codes among adults with hypertension and found differences in documentation and medical expenditures.
Researchers examined the...
06/26/2023
First Report Managed Care
News
CDC Data Shows Link Between High Costs and Prescription Nonadherence in Adults
06/21/2023
In 2021, medication nonadherence among adults was associated with costs, gender, disability status, insurance coverage, and other characteristics.
In 2021, medication nonadherence among adults was associated with costs, gender, disability status, insurance coverage, and other characteristics.
In 2021, medication nonadherence...
06/21/2023
First Report Managed Care
News
Blood Pressure Injections Recalled
05/26/2023
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products...
05/26/2023
Pharmacy Learning Network
News
Astral SteriTech Recalls 5 Injections Manufactured for 4 US Clients
05/26/2023
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II...
05/26/2023
Pharmacy Learning Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use